Nova Eye Medical (AU:EYE)
ASX:EYE
Holding AU:EYE?
Track your performance easily

Nova Eye Medical (EYE) Financial Statements

9 Followers

Nova Eye Medical Financial Overview

Nova Eye Medical's market cap is currently ―. The company's EPS TTM is AU$-0.042; its P/E ratio is -3.40; Nova Eye Medical is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 8.00MAU$ 17.80MAU$ 95.65MAU$ 15.37MAU$ 23.07M
Total AssetsAU$ 36.63MAU$ 41.99MAU$ 116.74MAU$ 99.89MAU$ 102.71M
Total DebtAU$ 1.94MAU$ 3.70MAU$ 3.34MAU$ 15.08MAU$ 15.00M
Net DebtAU$ -6.06MAU$ -14.10MAU$ -92.31MAU$ -291.00KAU$ -8.07M
Total LiabilitiesAU$ 6.23MAU$ 6.66MAU$ 16.16MAU$ 31.10MAU$ 27.45M
Stockholders EquityAU$ 30.40MAU$ 35.34MAU$ 100.59MAU$ 68.80MAU$ 75.26M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Nova Eye Medical Earnings and Revenue History

Nova Eye Medical Debt to Assets

Nova Eye Medical Cash Flow

Nova Eye Medical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis